Miransertib free base
Miransertib is an orally active, potent, selective AKT inhibitor. Miransertib binds and inhibits AKT activity in a non-ATP competitive manner, which may lead to inhibition of the PI3K/AKT signaling pathway. This may lead to reduced tumor cell proliferation and induce tumor cell apoptosis.
| Supplier | Alfa Cytology |
|---|---|
| Product # | BC0168 |
| Pricing | 5.0 mg, 10.0 mg, 25.0 mg, 50.0 mg, 100.0 mg, inquire |